Organization
Verity Pharmaceuticals
1 clinical trial
Clinical trial
A Multicenter, Randomized, Double-blind, Controlled Phase III Non-inferiority Study Assessing Efficacy and Safety of VERITY-BCG in Management of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) in BCG-naïve Patients.Status: Not yet recruiting, Estimated PCD: 2025-12-30